Literature DB >> 11063957

Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.

C Catena1, L Zingaro, D Casaccio, L A Sechi.   

Abstract

PURPOSE: The prothrombotic state that occurs in uremic patients may increase their cardiovascular risk. We studied hypertensive patients with mild-to-moderate impairment of renal function to determine if they had evidence of abnormalities in the coagulation system. SUBJECTS AND METHODS: Renal function was assessed in 382 patients with essential hypertension, in whom 24-hour creatinine clearance, urinary protein excretion, and microalbuminuria were measured. We evaluated the function of the coagulation system by measurement of platelet counts, prothrombin time, partial thromboplastin time, and plasma antithrombin III, fibrinogen, D-dimer, and prothrombin fragment 1 + 2 levels.
RESULTS: Impaired renal function, defined as a creatinine clearance of 30 to 89 mL per minute per 1.73 m(2) of body surface area, was found in 168 (44%) of the patients. Age, blood pressure, duration of hypertension, and plasma levels of fibrinogen, D-dimer, prothrombin fragment 1 + 2, and lipoprotein(a) were significantly greater in these patients than in those with normal renal function; these differences persisted after adjustment for potential confounders. Creatinine clearance was significantly and inversely correlated with levels of plasma fibrinogen (Spearman's rho = -0.26, P <0.001), D-dimer (rho = -0.33, P <0.001), and prothrombin fragment 1 + 2 (rho = -0.20, P <0.001). Levels of plasma fibrinogen (P = 0.009) and D-dimer (P = 0.003) were correlated with renal function independent of age, blood pressure, duration of hypertension, triglyceride level, urinary protein excretion, and erythrocyte sedimentation rate. Lipoprotein(a) levels were correlated with fibrinogen (rho = 0.16, P = 0.003) and D-dimer (rho = 0.26, P <0.001) levels.
CONCLUSIONS: Increased plasma levels of fibrinogen, D-dimer, and prothrombin fragment 1 + 2 are present in hypertensive patients with mildly decreased creatinine clearance, suggesting that the coagulation system is activated in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063957     DOI: 10.1016/s0002-9343(00)00567-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state.

Authors:  Cristiana Catena; GianLuca Colussi; Francesca Nait; Francesca Pezzutto; Flavia Martinis; Leonardo A Sechi
Journal:  World J Nephrol       Date:  2015-07-06

Review 2.  Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.

Authors:  Sana Khan; Soumya Pati; Shailja Singh; Mohd Akhtar; Piush Khare; Saba Khan; Sadat Shafi; Abul Kalam Najmi
Journal:  Int J Obes (Lond)       Date:  2021-10-22       Impact factor: 5.095

Review 3.  [Hemorrhaging during pregnancy].

Authors:  S Hofer; R Schreckenberger; B Heindl; K Görlinger; H Lier; H Maul; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

4.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

5.  Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension.

Authors:  Cristiana Catena; Gianluca Colussi; Valentina Fagotto; Leonardo A Sechi
Journal:  J Res Med Sci       Date:  2017-05-30       Impact factor: 1.852

6.  Effectiveness of Platelet Function Analyzer-100 for Laboratory Detection of Anti-Platelet Drug-Induced Platelet Dysfunction.

Authors:  Oh Joo Kweon; Yong Kwan Lim; Bohyun Kim; Mi Kyung Lee; Hye Ryoun Kim
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

7.  Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.

Authors:  Laura Gonzalez-Calero; Marta Martin-Lorenzo; Fernando de la Cuesta; Aroa S Maroto; Montserrat Baldan-Martin; Gema Ruiz-Hurtado; Helena Pulido-Olmo; Julian Segura; Maria G Barderas; Luis M Ruilope; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  Cardiovasc Diabetol       Date:  2016-01-16       Impact factor: 9.951

Review 8.  Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Francesco Summaria; Maria B Giannico; Giovanni P Talarico; Roberto Patrizi
Journal:  Nephrourol Mon       Date:  2015-07-22

9.  Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.

Authors:  Alyaa Abdelmaguid; Lara N Roberts; Laura Tugores; Jennifer R Joslin; Beverley J Hunt; Kiran Parmar; Danilo Nebres; Salah S Naga; Eman S Khalil; Kate Bramham
Journal:  J Thromb Haemost       Date:  2022-02-03       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.